IDT Australia (IDT) - RNA Opportunity Squeezed by BioNTech & CSL
The opportunity for IDT to establish itself as a significant player in mRNA drug manufacture in Australia has diminished in recent months.
415 Views
IDT Australia (IDT): Poised to Benefit from RNA and On-Shoring
DT Australia has a long track record as a manufacturer of pharmaceutical drugs, including both active pharmaceutical ingredients (API) and finished...
474 Views
Taxing Times For Australia
The Government's release of Re:think, its tax discussion paper, is a welcome development, designed to kick-start the conversation with the...
6k Views